REAL STORIES. REAL WORKERS. REAL STRENGTH.
Latest Stories
SK Pharmteco is planning to invest over $200 million in the next five years to enhance its California and Texas facilities, focusing on expanding peptide capacity and creating 100 new jobs. This investment showcases a commitment to growth in the pharmaceutical industry, which contributes to American competitiveness and skilled work opportunities.
Hanwha Defense USA announced plans to build a $2.2 billion munitions manufacturing campus at the U.S. Army’s Pine Bluff Arsenal in Arkansas, creating nearly 400 jobs and expanding domestic production capacity for artillery components.
Members of the House Appropriations Committee are investigating strategies to attract more young people to trades that support increased production for the defense industrial base. This initiative could potentially enhance American industry by strengthening the workforce in critical areas of defense production.
The FDA has approved Isembyld, the first ‘muscle-targeted’ treatment for Spinal Muscular Atrophy (SMA). With analysts predicting it to be a future blockbuster, this drug has shown promising results in clinical testing by improving motor function in patients already on standard therapies. This approval could have a significant impact on the pharma industry and potentially benefit American patients and healthcare providers.
UniQure is now awaiting a decision from the FDA on its application for Huntington’s gene therapy, following a challenging year of navigating U.S. regulatory hurdles. This development in the pharma industry could have implications for American healthcare innovation and the treatment of genetic disorders.
Gilead Sciences has unveiled a new 182,000ft² research center at its Foster City headquarters in California, dedicated to advancing medicines for challenging diseases. This development underscores the company’s commitment to innovation and could have positive implications for American pharmaceutical industry and healthcare.
Covenant, a Silicon Valley-backed defense startup, has inaugurated a 105,000-square-foot factory in Dallas to mass-produce its low-cost, long-range cruise missiles. The facility aims to reach an annual capacity of 5,000 missiles to meet growing demand from U.S. and allied military customers.
Rolls Royce completes a decade-long $1 billion investment to modernize and expand its Indiana manufacturing, assembly, and testing facilities, supporting key U.S. defense programs and employment of approximately 3,500 workers.
Chobani, the Greek yogurt maker, is purchasing a Pennsylvania plant from Keurig Dr Pepper to establish a new growth hub, expecting to generate more than 900 jobs. This investment highlights a significant move in the American manufacturing sector, showcasing a boost in production and job opportunities.
Key contract negotiations led by the United Steelworkers (USW)—with US Steel, and Cleveland Cliffs, approach their major deadlines on August 31, 2026. With BP Whiting seven months past its deadline, the pattern of last-minute bargaining highlights the USW’s strategic approach to coordinated negotiations amid critical industry issues.
Top Stories
